Edwin Jonathan Tucker's most recent trade in Jasper Therapeutics Inc was a trade of 90,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jasper Therapeutics Inc | Edwin Jonathan Tucker | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Edwin Jonathan Tucker | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Edwin Jonathan Tucker | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 4.17 per share. | 07 Jun 2024 | 400 | 400 | - | 4.2 | 1,669 | Voting Common Stock |
| Jasper Therapeutics Inc | Edwin Jonathan Tucker | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Edwin Jonathan Tucker | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 13.51 per share. | 10 Nov 2021 | 70 | 45,838 (0%) | 0% | 13.5 | 946 | Common Stock |
| Mirum Pharmaceuticals Inc | Edwin Jonathan Tucker | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 14.62 per share. | 10 May 2021 | 1,483 | 39,007 (0%) | 0% | 14.6 | 21,681 | Common Stock |
| Mirum Pharmaceuticals Inc | Edwin Jonathan Tucker | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 1,082 | 69,751 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Edwin Jonathan Tucker | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.70 per share. | 05 Mar 2021 | 1,082 | 37,524 (0%) | 0% | 7.7 | 8,331 | Common Stock |
| Mirum Pharmaceuticals Inc | Edwin Jonathan Tucker | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Edwin Jonathan Tucker | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.70 per share. | 28 Dec 2020 | 4,167 | 36,442 (0%) | 0% | 7.7 | 32,086 | Common Stock |
| Mirum Pharmaceuticals Inc | Edwin Jonathan Tucker | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 4,167 | 70,833 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Edwin Jonathan Tucker | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 15.27 per share. | 10 Nov 2020 | 1,275 | 32,275 (0%) | 0% | 15.3 | 19,464 | Common Stock |
| Mirum Pharmaceuticals Inc | Edwin Jonathan Tucker | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2020 | 25,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Edwin Jonathan Tucker | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.70 per share. | 30 Oct 2020 | 25,000 | 31,000 (0%) | 0% | 7.7 | 192,500 | Common Stock |